立方制药：10月28日召开董事会会议

Company Overview - Lifan Pharmaceutical (SZ 003020) announced the convening of its sixth second board meeting on October 28, 2025, to review the proposal for the "2025 Third Quarter Report" [1] - As of the report, Lifan Pharmaceutical has a market capitalization of 5.4 billion yuan [1] Revenue Composition - For the first half of 2025, Lifan Pharmaceutical's revenue composition is as follows: - Pharmaceutical manufacturing accounted for 91.14% - Pharmaceutical retail accounted for 7.71% - Other segments accounted for 1.16% [1]